DOC is a high-yield healthcare REIT priced like a distressed office landlord—despite a resilient medical-office core and a “free option” on a future lab-cycle recovery.
Overview
As of Jan 3, 2026, Physicians Realty Trust—now fully integrated into and operating under Healthpeak Properties, Inc. while trading as **DOC**—is a scaled healthcare REIT whose investment case is defined by a stark split between **stable outpatient medical cash flows** and a **cyclically stressed life science (lab) platform**. The March 1, 2024 “merger of equals” combined legacy Healthpeak’s life science/medical office assets with legacy DOC’s pure-play outpatient focus, creating a ~$21B+ gross asset value platform designed to benefit from the convergence of healthcare “Discovery” and “Delivery.” Nearly two years on, the thesis is operationally intact but market perception is sharply negative because the lab segment has faced oversupply and a biotech funding downturn, while the outpatient medical segment has delivered the predictable stability expected (high retention, steady rent growth). Led by CEO Scott Brinker, the company pursued aggressive integration and **internalization of property management**, targeting **$40M synergies in 2024** and **$20M more by YE2025**—which management says are being met or exceeded. Financially, GAAP results are noisy (Q3’25 net loss of $(0.17)/share) due to non-cash and merger items, but REIT cash metrics are steadier (Q3’25 **FFO as Adjusted $0.46/share**, a beat). DOC enters 2026 near 52-week lows (~$16.08) with a high dividend yield (~7.6%) that appears covered by AFFO (payout ~69%), despite the market implicitly pricing distress or long-term impairment. The balance sheet remains investment grade (**BBB+**, ~5.3x Net Debt/Adj. EBITDAre, ~$2.7B liquidity). The report frames DOC as a patient-capital opportunity if the lab market is a cyclical trough rather than a secular collapse, with meaningful upside if/when lab fundamentals stabilize and the multiple rerates.